Richard T. Ellison III, MD
Tenofovir-Based HIV PrEP Decreases HSV-2 Acquisition
Stephen G. Baum, MD
Intensified ART for Patients with Acute or Recent HIV Infection?
Carlos del Rio, MD
Cardiovascular Disease Risk Markers in HIV-Infected Patients Receiving Abacavir or Tenofovir
Rajesh T. Gandhi, MD
Abigail Zuger, MD
Changing Patterns in Causes of Death After ART Initiation
Keith Henry, MD
Nonoccupational Postexposure Prophylaxis: High Attrition Rates
Sonia Nagy Chimienti, MD
FLAMINGO: Dolutegravir vs. Darunavir for Initial Treatment of HIV
Rajesh T. Gandhi, MD
Tadalafil Might Ease Symptoms of Benign Prostatic Hyperplasia
Allan S. Brett, MD
Abigail Zuger, MD